Skip to content

Ranolazine

Ranolazine is a medication primarily recognised by the brand name Ranexa, used to manage chronic chest pain. It assists by optimising how the heart uses its energy supply during periods of exertion. One specific prolonged-release formulation is listed, offering a focused option for those requiring stability in their cardiac treatment plan.

Ranexa

Angina Pectoris

500 · 1000mg

Ranolazine 500mg and 1000mg prolonged-release tablets, used in the management of stable angina pectoris. It blocks the late sodium current.

From$1.51/ tabletView

Key points

  • Inhibits the late sodium current in heart cells, preventing a calcium build-up that would otherwise waste oxygen.
  • Reserved for people whose chest pain persists despite other heart medicines, rather than being a first-line option.
  • Marketed as Ranexa, a prolonged-release tablet meant to maintain steady drug levels through the day.
  • Because the liver and kidneys clear it, existing problems with either organ affect how the dose behaves.

What is Ranolazine?

Ranolazine is a pharmaceutical agent classified as an anti-anginal medication. It provides a distinct approach to managing heart-related discomfort, differentiating it from traditional therapies that primarily target heart rate or blood pressure. Its unique mechanism makes it a clinical consideration for long-term symptom control in patients who require alternative support.

What Ranolazine is used for

Ranolazine is primarily indicated for Stable Angina Pectoris. It serves those who continue to experience chronic chest pain despite using other cardiac medicines. By incorporating this active compound into a broader Heart & Blood Pressure management strategy, individuals may notice a reduction in the frequency of anginal episodes.

How does Ranolazine work?

This medication operates by altering the electrical currents within heart cells. It inhibits the late sodium current, which prevents an excess of calcium from building up inside the cells. This cellular optimisation allows the heart to function more efficiently, particularly when oxygen supply is restricted, thereby easing the associated pain.

Ranolazine brands and forms

The primary formulation available is the prolonged-release tablet. This delivery method is designed to provide a steady, consistent concentration of the medication in your system throughout the day. While Ranexa acts as the reference originator, generic tablets follow the same release profile to ensure consistent therapeutic support for ongoing management.

Safety overview for Ranolazine

What to check before using this medicine

Discuss your full medical history with a doctor, focusing specifically on liver or kidney conditions, as these affect how the body clears the drug.

Possible reactions and tolerability

Common experiences may include dizziness, headache, or nausea. Observe your body for any changes while starting or adjusting a regimen.

Interactions and health factors

Ranolazine may interact with other medicines, particularly those affecting heart rhythm or metabolism. Always review your current list of supplements and medicines with a clinician to ensure compatibility. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.

Further reading